ArticleCEN case reports2026
A case of immunofluorescence-negative light chain deposition disease diagnosed by mass spectrometry.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 53-year-old man was referred to our department for the evaluation of kidney dysfunction and edema. Kidney biopsy revealed nodular glomerular lesions; however, immunofluorescence showed no specific deposition of immunoglobulins or light chains, and a definitive diagnosis could not be confirmed. Serum and urine immunofixation electrophoresis detected κ-type Bence Jones protein, raising suspicion of monoclonal immunoglobulin-related kidney disease. Bone marrow examination led to a diagnosis of multiple myeloma. Electron microscopy revealed band-like, powdery, electron-dense deposits extending from the glomerular basement membrane to the subendothelial area as well as deposits along the tubular basement membranes, suggestive of monoclonal immunoglobulin deposition disease. However, additional evaluation using immunofluorescence on paraffin-embedded tissues and immunohistochemical staining failed to demonstrate light-chain deposition, and a pathological relationship between the plasma cell disorder and kidney lesion could not be established. Laser microdissection followed by liquid chromatography-tandem mass spectrometry identified κ light chain deposition, leading to a definitive diagnosis of light chain deposition disease and providing pathological evidence linking the plasma cell disorder to the kidney lesion. Plasma cell-directed therapy was subsequently initiated, resulting in improved kidney function and the avoidance of dialysis. This case highlights the potential utility of mass spectrometry for establishing a definitive diagnosis and guiding therapeutic decision-making when light-chain deposition cannot be demonstrated by conventional or additional immunostaining.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.